TY - BOOK AU - Margus Viigimaa AU - Charalambos Vlachopoulos AU - Michael Doumas TI - Erectile Dysfunction in Hypertension and Cardiovascular Disease: A Guide for Clinicians SN - 3319082728 PY - 2014/// CY - North Estonia Medical Centre Tallinn University of Technology Tallinn Estonia PB - Springer KW - N1 - Contents Definition and Assessment of Erectile Dysfunction 1 Epidemiology of Erectile Dysfunction in Hypertension 9 Pathophysiology of Erectile Dysfunction 19 Erectile Dysfunction and Testosterone 29 The Role of the ReninAngiotensin System in Erectile Dysfunction Present and Future 38 Erectile Dysfunction and Target Organ Damage 51 Erectile Dysfunction in Coronary Artery Disease and Heart Failure 59 Erectile Dysfunction as an Early Diagnostic Window for Asymptomatic Coronary Artery Disease 72 Endocrine Disorders and Erectile Dysfunction 139 The Metabolic Investigation of Erectile Dysfunction Cardiometabolic Risk Stratification 145 Erectile Dysfunction in the Elderly 159 Lifestyle Modification in Erectile Dysfunction and Hypertension 167 Antihypertensive Drug Therapy and Erectile Dysfunction 175 PDE5 Inhibitors for the Treatment of Erectile Dysfunction in Patients with Hypertension 185 Management of Erectile Dysfunction Beyond PDE5 Inhibitors 194 Cognitive Behavioral Therapy in Sexual Dysfunction 205 The Prognostic Role of Erectile Dysfunction for Cardiovascular Events 83 Erectile Dysfunction in Chronic Kidney Disease 96 Erectile Dysfunction and Sleep Apnea 109 Diabetes Mellitus and Erectile Dysfunction 119 The Association Between Dyslipidemia and Its Treatment with Erectile Dysfunction 129 N2 - This concise guide to the often overlooked association between erectile dysfunction and hypertension/cardiovascular disease covers a wide range of aspects of importance to the clinician. It examines the impact of antihypertensive drug therapy on erectile function and explains how the management of erectile dysfunction in hypertensive patients depends on a variety of factors. Different treatment approaches are described, including lifestyle modification, PDE-5 inhibitors and other novel agents and behavioral therapy and helpful therapeutic algorithms are presented. A further focus of the book is the potential role of erectile dysfunction as an early diagnostic indicator of asymptomatic coronary artery disease and a prognostic marker for cardiovascular events. In addition, key background information is supplied on epidemiology and pathophysiology, and the significance of erectile dysfunction in different patient groups, such as the elderly and those with chronic kidney disease, is examined. Erectile dysfunction is a major public health problem affecting more than ten percent of the general male population and is now considered to be predominantly of vascular origin. This book will be informative and of practical value for all practitioners responsible for caring for the very many patients who experience erectile dysfunction in the setting of hypertension and cardiovascular disease ER -